BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
This company is included in Intelligence Lab

Recursion Pharmaceuticals

Recursion Pharmaceuticals logo

Website
https://www.recursion.com/
Founded
2013

Technologies

AI Companies (Drug Discovery) Gene Therapy Startups Pharmaceutical and Drug Discovery

Recursion Pharmaceuticals is a biotechnology company based in Salt Lake City. Recursion combines experimental biology, automation, and artificial intelligence in a massively parallel system to quickly and efficiently identify treatments for any disease which can be modeled at the cellular level. From its initial and continued focus on drug repurposing to treat rare diseases, Recursion has broadened its platform to probe rich data from high-throughput automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. Recursion is aggressively leveraging technology to build a robust and reliable map of human cellular biology, which will enable a radical shift in the pace and scale at which new treatments will benefit patients.


Articles Mentioning This Company

How Big Pharma Adopts AI To Boost Drug Discovery

How Big Pharma Adopts AI To Boost Drug Discovery

Oct. 9, 2025     Articles
(Last updated: October 2025) Since 1950, when Alan Turing introduced the concept of 'thinking machines', artificial intelligence has steadily advanced—from the rise of neural networks in the 1980s to the release of OpenAI’s GPT-3 in 2020, which paved the way for ChatGPT in 2022. Today, AI has become an integral …

17 Companies Pioneering AI Foundation Models in Pharma and Biotech

Sept. 30, 2025     Business Intelligence
Foundation models represent a relatively new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. Foundation models are a class of large-scale machine learning models, typically based on deep learning architectures such as transformers, that are trained on massive datasets encompassing diverse types of data. The …
13 Publicly Traded AI-driven Drug Discovery Companies

13 Biotechs Utilizing AI-based Research Platforms

June 18, 2024     Articles
According to our intelligence report, more than 450 life sciences companies in the categories "startups" and "scaleups" are actively using machine learning and deep learning-based predictive and generative capabilities to augment their research strategies.  Some companies are incorporating AI tools to improve specific stages of drug discovery and development, for …

R&D Platform

Conduct experimental biology at scale by testing thousands of compounds on hundreds of cellular disease models in parallel. Allows researchers to: Rapidly identify new indications for many known drugs and shelved assets.

News

  • 2025-10-29
    Recursion Completes Whole-Genome Microglia Map With Roche and Genentech
  • 2025-08-05
    Recursion Reports Q2 2025 with $7M Sanofi Milestone, Announces Clinical Updates
  • 2025-06-07
    MIT and Recursion Launch Boltz-2, Open-Source AI Foundation Model for Structure and Binding Affinity Prediction
  • 2024-12-09
    Recursion Reports Encouraging Interim Phase 1 Data a Selective CDK7 Inhibitor
  • 2024-08-08
    Breaking: In Arguably the Largest AI in Bio Deal, Recursion Acquires UK-based "End-to-End" AI Biotech Exscientia
  • 2024-05-14
    Recursion Unveils BioHive-2, Fastest Pharma-Owned Supercomputer
  • 2024-04-03
    New Landmark Report Unveils a Decade of AI Transformation in Drug Discovery
  • 2024-03-11
    Recursion Expands Its Presence with a New London Office and Bolsters Scientific Advisory Team
  • 2022-06-06
    Insilico Medicine Snaps Up $60M to Create Robotic Lab of the Future

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.